COO Quote, Financials, Valuation and Earnings

OrthoPediatrics has a net margin of 8.75% compared to The Cooper Companies's net margin of -20.34%. The Cooper Companies's return on equity of 5.15% beat OrthoPediatrics's return on equity of -11.21%.

The Cooper Companies has a consensus price target of $94.59, signalling upside risk potential of 33.35%. On the other hand OrthoPediatrics has an analysts' consensus of $36.43 which suggests that it could grow by 69.99%. Given that OrthoPediatrics has higher upside potential than The Cooper Companies, analysts believe OrthoPediatrics is more attractive than The Cooper Companies.

The Cooper Companies has a beta of 0.979, which suggesting that the stock is 2.098% less volatile than S&P 500. In comparison OrthoPediatrics has a beta of 1.084, suggesting its more volatile than the S&P 500 by 8.356%.

The Cooper Companies has a quarterly dividend of $0.01 per share corresponding to a yield of 0%. OrthoPediatrics offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. The Cooper Companies pays -- of its earnings as a dividend. OrthoPediatrics pays out -- of its earnings as a dividend.

The Cooper Companies quarterly revenues are $1B, which are larger than OrthoPediatrics quarterly revenues of $52.4M. The Cooper Companies's net income of $87.7M is higher than OrthoPediatrics's net income of -$10.7M. Notably, The Cooper Companies's price-to-earnings ratio is 34.43x while OrthoPediatrics's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Cooper Companies is 3.57x versus 2.34x for OrthoPediatrics. Usually stocks with elevated PS ratios are considered overvalued.

Innovative Eyewear has a net margin of 8.75% compared to The Cooper Companies's net margin of -391.35%. The Cooper Companies's return on equity of 5.15% beat Innovative Eyewear's return on equity of -97.69%.

The Cooper Companies has a consensus price target of $94.59, signalling upside risk potential of 33.35%. On the other hand Innovative Eyewear has an analysts' consensus of $7.00 which suggests that it could grow by 211.11%. Given that Innovative Eyewear has higher upside potential than The Cooper Companies, analysts believe Innovative Eyewear is more attractive than The Cooper Companies.

The Cooper Companies has a beta of 0.979, which suggesting that the stock is 2.098% less volatile than S&P 500. In comparison Innovative Eyewear has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

The Cooper Companies has a quarterly dividend of $0.01 per share corresponding to a yield of 0%. Innovative Eyewear offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. The Cooper Companies pays -- of its earnings as a dividend. Innovative Eyewear pays out -- of its earnings as a dividend.

The Cooper Companies quarterly revenues are $1B, which are larger than Innovative Eyewear quarterly revenues of $454.5K. The Cooper Companies's net income of $87.7M is higher than Innovative Eyewear's net income of -$1.8M. Notably, The Cooper Companies's price-to-earnings ratio is 34.43x while Innovative Eyewear's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Cooper Companies is 3.57x versus 2.53x for Innovative Eyewear. Usually stocks with elevated PS ratios are considered overvalued.

NexGel has a net margin of 8.75% compared to The Cooper Companies's net margin of -25.37%. The Cooper Companies's return on equity of 5.15% beat NexGel's return on equity of -59.55%.

The Cooper Companies has a consensus price target of $94.59, signalling upside risk potential of 33.35%. On the other hand NexGel has an analysts' consensus of $6.00 which suggests that it could grow by 154.24%. Given that NexGel has higher upside potential than The Cooper Companies, analysts believe NexGel is more attractive than The Cooper Companies.

The Cooper Companies has a beta of 0.979, which suggesting that the stock is 2.098% less volatile than S&P 500. In comparison NexGel has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

The Cooper Companies has a quarterly dividend of $0.01 per share corresponding to a yield of 0%. NexGel offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. The Cooper Companies pays -- of its earnings as a dividend. NexGel pays out -- of its earnings as a dividend.

The Cooper Companies quarterly revenues are $1B, which are larger than NexGel quarterly revenues of $2.8M. The Cooper Companies's net income of $87.7M is higher than NexGel's net income of -$712K. Notably, The Cooper Companies's price-to-earnings ratio is 34.43x while NexGel's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Cooper Companies is 3.57x versus 1.60x for NexGel. Usually stocks with elevated PS ratios are considered overvalued.

Staar Surgical has a net margin of 8.75% compared to The Cooper Companies's net margin of -127.29%. The Cooper Companies's return on equity of 5.15% beat Staar Surgical's return on equity of -17.97%.

The Cooper Companies has a consensus price target of $94.59, signalling upside risk potential of 33.35%. On the other hand Staar Surgical has an analysts' consensus of $19.10 which suggests that it could grow by 11.18%. Given that The Cooper Companies has higher upside potential than Staar Surgical, analysts believe The Cooper Companies is more attractive than Staar Surgical.

The Cooper Companies has a beta of 0.979, which suggesting that the stock is 2.098% less volatile than S&P 500. In comparison Staar Surgical has a beta of 0.632, suggesting its less volatile than the S&P 500 by 36.76%.

The Cooper Companies has a quarterly dividend of $0.01 per share corresponding to a yield of 0%. Staar Surgical offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. The Cooper Companies pays -- of its earnings as a dividend. Staar Surgical pays out -- of its earnings as a dividend.

The Cooper Companies quarterly revenues are $1B, which are larger than Staar Surgical quarterly revenues of $42.6M. The Cooper Companies's net income of $87.7M is higher than Staar Surgical's net income of -$54.2M. Notably, The Cooper Companies's price-to-earnings ratio is 34.43x while Staar Surgical's PE ratio is 49.73x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Cooper Companies is 3.57x versus 3.05x for Staar Surgical. Usually stocks with elevated PS ratios are considered overvalued.